• Science & Technology
• Health & Medicine

Gene editing technology could help engineer better cancer targeting immune cells

We explore how the latest gene editing technology could help our scientists engineer immune cells to precisely target and kill cancer cells. We explore how the latest gene editing technology could help our scientists engineer immune cells to precisely target and kill cancer cells.

15 April 2016

• Health & Medicine
• Science & Technology

Virtual reality and precision diagnosis among shortlist for our Grand Challenge

Find out the details of the nine ideas that could answer one of our Grand Challenges in cancer prevention, diagnosis and treatment. Find out the details of the nine ideas that could answer one of our Grand Challenges in cancer prevention, diagnosis and treatment.

14 April 2016

Cancer Research UK shortlists teams for £20m Grand Challenge to tackle cancer’s toughest problems

Cancer Research UK has today shortlisted nine teams for the final stages of its £20m Grand Challenge award. Cancer Research UK has today shortlisted nine teams for the final stages of its £20m Grand Challenge award.

14 April 2016

• Health & Medicine

Patients of the future – part 1: diagnosis

We unpick some futuristic ideas and see where the research and technology is at today - and how far away we are from turning science fiction into fact. We unpick some futuristic ideas and see where the research and technology is at today - and how far away we are from turning science fiction into fact.

13 April 2016

• Science & Technology
• Health & Medicine

US hospital commits to lung cancer ‘liquid biopsy’

Analysing tumour DNA in blood samples could help doctors offer ‘targeted’ treatments best suited to a patient’s lung cancer. Analysing tumour DNA in blood samples could help doctors offer ‘targeted’ treatments best suited to a patient’s lung cancer.

8 April 2016

• Health & Medicine

Scientists identify possible double whammy to attack leukaemia

Cancer Research UK scientists have identified a potential double drug combination against B-cell acute lymphoblastic leukaemia. Cancer Research UK scientists have identified a potential double drug combination against B-cell acute lymphoblastic leukaemia.

7 April 2016

• Health & Medicine
• Science & Technology

Immunotherapy and chemo combination shows early promise for pancreatic cancer

An experimental drug that stimulates the immune system, used in combination with chemotherapy, shrank tumours in patients with pancreatic cancer. An experimental drug that stimulates the immune system, used in combination with chemotherapy, shrank tumours in patients with pancreatic cancer.

6 April 2016

• Science & Technology
• Health & Medicine

Microbubbles, a cancer cell shape sorter, and artificial intelligence – our latest innovative science projects

We take a look at five exciting projects that have just been funded by our Pioneer Award. We take a look at five exciting projects that have just been funded by our Pioneer Award.

4 April 2016

• Science & Technology

Scientists discover new way to tackle challenging children’s brain tumours

Scientists have discovered why a curable type of children’s brain tumour is so responsive to chemotherapy. Scientists have discovered why a curable type of children’s brain tumour is so responsive to chemotherapy.

31 March 2016

• Science & Technology
• Health & Medicine

Blood analysis could offer a real-time ‘snapshot’ of melanoma treatment

We explore the latest research from our scientists in Manchester that's tracking how melanomas respond to treatment by analysing patient blood samples. We explore the latest research from our scientists in Manchester that's tracking how melanomas respond to treatment by analysing patient blood samples.

15 March 2016

• Science & Technology
• Health & Medicine

Blocking the escape routes: how an HIV drug exposes skin cancer’s weaknesses

A new study from our scientists has found that treating melanoma cells with an HIV drug could make them more sensitive to a 'targeted' cancer drug. A new study from our scientists has found that treating melanoma cells with an HIV drug could make them more sensitive to a 'targeted' cancer drug.

14 March 2016

• Health & Medicine

‘Unprecedented’ breast cancer trial results explained

UK researchers running a clinical trial have presented some exciting preliminary results at a European breast cancer conference UK researchers running a clinical trial have presented some exciting preliminary results at a European breast cancer conference

11 March 2016